Market access focus Stratis specializes in market access strategy, payer engagement, patient support design, and real-world evidence for pharmaceutical, biotech, and academic clients, indicating strong cross-selling potential to firms seeking integrated access solutions across pre- and post-launch.

Launch optimization With capabilities in launch planning and execution, HEOR, and field reimbursement strategy, there are sales opportunities to offer end-to-end launch services that align pricing, payer conversations, and patient services to accelerate uptake.

Integrated services Stratis combines market access, patient support, analytics, and activation tools, suggesting potential to upsell bundled offerings to clients needing cohesive programs that translate insights into operational results.

Industry positioning Being part of Nexus Health under the Lockwood Group and serving pharma, biotech, and academic organizations positions Stratis to pursue partnerships with large life sciences firms seeking specialized access strategy and real-world evidence capabilities.

Technology enablement The tech stack and emphasis on advanced analytics and real-world evidence indicate an opportunity to propose data-driven engagement platforms and digital patient support enhancements that improve payer pull-through and market access outcomes.